Relmada Therapeutics Stock (NASDAQ: RLMD) stock price, news, charts, stock research, profile.
Open | $3.19 |
Close | $4.10 |
Volume / Avg. | 418.51K / 92.78K |
Day Range | 3.18 - 4.12 |
52 Wk Range | 2.42 - 7.22 |
Market Cap | $120.70M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 80 |
Short Interest | 5.24% |
Days to Cover | 13.76 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.
Other companies in Relmada Therapeutics’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS) and Nutriband (NASDAQ:NTRB).
There is no analysis for Relmada Therapeutics.
Relmada Therapeutics has a consensus price target of $15.17.
The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $4 last updated July 9, 2024 at 6:39 PM EDT.
There are no upcoming dividends for Relmada Therapeutics.
Relmada Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Relmada Therapeutics.
Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.